
Cytek Biosciences (CTKB) Stock Sees Modest Fair Value Lift As Analysts Weigh Profitability
Cytek Biosciences is back in focus as fair value estimates have shifted from about US$5.69 to roughly US$6.17 per share, reflecting a modest reset in price targets. Analysts clust…